Publications for Dr Mike Khan - Department of Biological Sciences
- Betteridge D.J., and Khan M*. Inherited disorders of HDL metabolism. (1998). Lancet 351:1903-4
- Pelengaris SA, Littlewood T, Khan M*, Elia G and Evan G. Reversible activation of c-Myc in skin- induction of a complex neoplastic phenotype by a single oncogenic lesion. (1999). Molecular Cell 6: 565-577
- Pelengaris SA and Khan M. Oncogenic cooperation in beta cell neoplasia. (2001). Endocrine Related Cancer. 8, 307-314,
- Pelengaris, S*., Khan, M*., and Evan, G. Suppression of Myc-induced apoptosis in beta cells exposes multiple innate oncogenic properties of Myc sufficient to trigger immediate carcinogenic progression (2002). Cell, 109(3): 321-334 (Joint first authors).
- Mattu RK, Trevelyan J, Needham EW, Khan M*, Adiseshiah MA, Richter D, Murray RG, Betteridge DJ. Lipoprotein lipase gene and microalbuminuria. Diabetologia 2002 Jun;45(6):905-913.
- Pelengaris, S., Khan, M., and Evan, G. c-Myc: more than just a matter of life and death. Nature-reviews cancer. (2002). 2: 764-776.
- Pelengaris SA and Khan M*. The many faces of c-Myc. Arc. Biochem. and Biophys. (2003). 416: 129-136.
- Pelengaris SA and Khan M*. c-Myc: Potential treatment target in cancer and other disorders of cell growth. EOTT, (2003). In press.
- Khan, M*., Pelengaris, S., Cooper, M., Smith, C., Evan, G., and Betteridge, DJ. (2003). Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis. In press.
- John Betteridge and Michael Khan. Statins and coronary artery disease (first edition). 2001. Science Press. ISBN 1-85873-251-4. Complete textbook, published in the UK and translations in Spanish, and Greek.
- John Betteridge and Michael Khan. Statins and coronary artery disease (second edition). 2003. Science Press.
- Michael Khan and Stella Pelengaris. Lipids and diabetes. 2002. Current Medical Literature. ISBN 1-85009-182-X Complete textbook.
|
|